Modern Rheumatology

Article	Citations
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD	287
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication	48
Depression, physical function, and disease activity associated with frailty in patients with rheumatoid arthritis	25
Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials	24
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study	23
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib	21
Treatment strategies for elderly-onset rheumatoid arthritis in the new era	20
Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study	19
Clinical features of elderly-onset Adult-onset Still’s disease	18
Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospec	17
Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, random	17
Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III stu	15
SAPHO syndrome and pustulotic arthro-osteitis	15
Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review	14
Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthri	14
Chronic postsurgical pain after total knee arthroplasty: A prospective cohort study in Japanese population	13
Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit	13
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration	13
Prevalence and clinical association with calcinosis cutis in early systemic sclerosis	13
Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches	13
A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs	13
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance	12
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis	12
Efficacy and safety of apremilast for 3 months in Behçet’s disease: A prospective observational study	12
Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the manageme	12

Annual variation rate of KL-6 for predicting acute exacerbation in patients with rheumatoid arthritis-associated interstitial lung disease	12
Pool-based exercise for amelioration of pain in adults with fibromyalgia syndrome: A systematic review and meta-analysis	12
Recent advances in IgG4-related kidney disease	11
Role of dietary patterns and factors in determining the risk of knee osteoarthritis: A meta-analysis	11
Effects of brief self-exercise education on the management of chronic low back pain: A community-based, randomized, parallel-group pragmatic trial	11
Pyroptosis inhibition alleviates potassium oxonate- and monosodium urate-induced gouty arthritis in mice	11
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-w	11
Central sensitization in axial spondyloarthritis: An explorative study with quantitative sensory testing and clinical scales	11
Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?	11
Glucocorticoids in the treatment of IgG4-related disease—Prospects for new international treatment guidelines	10
Non-radiographic axial spondyloarthritis	10
Potential of the prognostic nutritional index to determine the risk factor for severe infection in elderly patients with rheumatoid arthritis	10
Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome	10
Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis	10
Epidemiological study of osteonecrosis of the femoral head using the national registry of designated intractable diseases in Japan	10
Macrophage activation syndrome in patients with adult-onset Still’s disease under tocilizumab treatment: A single-center observational study	10
The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study	10
COVID-19 in patients with Behçet’s disease: Outcomes and rate of Behçet’s exacerbations in a retrospective cohort	10
The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE	10
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study	9
The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study	9
The prevalence, burden of disease, and healthcare utilization of patients with eosinophilic granulomatosis with polyangiitis in Japan: a retrospective, descriptive cohort claims database study	9
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine	9
Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study	9
Interluekin-6 inhibitors for the treatment of adult-onset Still’s disease	9
Questionnaire survey on transitional care for patients with juvenile idiopathic arthritis (JIA) and families	9
Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis–associated refractory macrophage activation syndrome	9
Evaluation of the Central Sensitization Inventory Score in elderly adults with musculoskeletal examination	9
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis	9
Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease	9
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid	9
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial	9
The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model	9
Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan	9
Management of sarcopenia in patients with rheumatoid arthritis	9
Ultrasound assessment of sarcopenia in patients with rheumatoid arthritis	9
Distinct clinical characteristics of pediatric Behçet’s syndrome: A study from a referral center in China	9
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study	9
How should rheumatologists manage glucocorticoid-induced hyperglycemia?	8
Long-term safety and effectiveness of mycophenolate mofetil in adults with lupus nephritis: a real-world study in Japan	8
Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever	8
Clinical features and prognosis of nocardiosis in patients with connective tissue diseases	8
Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study	8
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis	8
A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years	8
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort	8
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis	8
Evaluation of retinal vascularization by optical coherence tomography angiography (OCTA) in rheumatoid arthritis, and its relationship with disease activity	8
Deep learning methods in the diagnosis of sacroiliitis from plain pelvic radiographs	8
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort	8

Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis	8
The relationship between platelet to albumin ratio and disease activity in axial spondyloarthritis patients	8
Differences of 2-year longitudinal changes of locomotive syndrome among patients treated with thoracolumbar interbody fusion, total hip arthroplasty, and total knee arthroplasty for degenerative disea	7
A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study	7
Automatic quantification and grading of hip bone marrow oedema in ankylosing spondylitis based on deep learning	7
A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan	7
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics	7
MicroRNA-106b overexpression suppresses synovial inflammation and alleviates synovial damage in patients with rheumatoid arthritis	7
Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: A single-centre experience	7
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids	7
Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication	7
A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting	7
Relationship between locomotive syndrome and frailty in rheumatoid arthritis patients by locomotive syndrome stage	7
Association between low back pain and quality of life in patients with rheumatoid arthritis according to patient-reported outcomes using the Japanese Orthopaedic Association Back Pain Evaluation Quest	7
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Comm	7
Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: A randomized clinical pilot study	7
Urticaria and increased risk of rheumatoid arthritis: a two-sample Mendelian randomisation study in European population	7
Perspectives on current and emerging therapies for immunoglobulin G4–related disease	6
Patients’ perspectives of rheumatoid arthritis treatment: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines	6
JKAP serves as a potential biomarker for the evaluation of inflammatory condition, disease activity, and treatment response to TNF inhibitor in ankylosing spondylitis patients	6
Foot orthosis treatment improves physical activity but not muscle quantity in patients with concurrent rheumatoid arthritis and sarcopenia	6
Long-term outcome and predictors of remission in Behçet’s disease in daily practice	6
Association between magnitude of femoral head collapse and quality of life in patients with osteonecrosis of the femoral head	6
Efficacy of local oxygen–ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: A randomized controlled study	6
Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis	6
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives	6
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)	6
Clinical features and outcomes of childhood polyarteritis nodosa: A single referral center experience	6
Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis	6
Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset	6
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database	6
Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the managemen	6
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort	6
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)	6
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors	6
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis	6
Predictors of persistent inflammation in children with familial Mediterranean fever	6
Geographic variations in rheumatoid arthritis treatment in Japan: A nationwide retrospective study using the national database of health insurance claims and specific health checkups of Japan	5
Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease	5
Predictors of infliximab refractory intestinal Behçet’s syndrome: A retrospective cohort study from the Shanghai Behçet’s syndrome database	5
Geographic distribution of the incidence of osteonecrosis of the femoral head in Japan and its relation to smoking prevalence	5
Efficacy and tolerability of subcutaneously administered methotrexate including dose escalation in long-term treatment of rheumatoid arthritis in a Japanese population	5
Pregnancy-associated risk factors and incidence of systemic sclerosis in primiparous women: A nationwide population-based cohort study	5
MEFV E148Q variant is more associated with familial Mediterranean fever when combined with other non-exon 10 MEFV variants in Japanese patients with recurrent fever	5
Symptoms compatible with Rome IV functional bowel disorder in patients with ankylosing spondylitis	5
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis	5
Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study	5
Radiographic factors associated with painful callosities after forefoot surgery in patients with rheumatoid arthritis	5
miR-144-3p aggravated cartilage injury in rheumatoid arthritis by regulating BMP2/PI3K/Akt axis	5
Apremilast in a Japanese subgroup with Behçet’s syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study	5
The implication of long non-coding RNA expression profile in rheumatoid arthritis: Correlation with treatment response to tumor necrosis factor inhibitor	5
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study	5
Two distinct subsets of LDGs (low density granulocytes) in ANCA-associated vasculitis	5
Therapeutic effect of targeting Substance P on the progression of osteoarthritis	5
Ultrasonography of IgG4-related dacryoadenitis and sialadenitis: Imaging features and clinical usefulness	5
Have the radiographic characteristics of total knee arthroplasty recipients in rheumatoid arthritis changed after the induction of biologic disease modifying antirheumatic drugs?	5
Improvement of locomotive syndrome after total hip arthroplasty: A two-year longitudinal cohort study	5
Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world	5
Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance	5
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study	5
Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study	5
Effect of administration of immunoglobulin preparations on the results of tests for autoantibodies	5
Minimum 10 years clinical results of an anatomical short stem with a proximal hydroxyapatite coating	5
Extension contracture stiff knee in haemophilia: Surgical timing and procedure for total knee arthroplasty	5
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort	5
Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis	5
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis	5
Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study	5
Is musculoskeletal pain related to locomotive syndrome even in young and middle-aged adults?	5
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate	5
High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort	5
Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis	5
Ultrasonography and contrast-enhanced ultrasound for activity assessment in 115 patients with carotid involvement of Takayasu arteritis	4
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses	4
Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease	4
Evaluation of quality and reliability of musculoskeletal ultrasound videos on YouTube	4
Status of fracture risk assessment and osteoporosis treatment in Japanese patients with rheumatoid arthritis	4
Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study	4
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study	4
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study	4

Comparison of physical activity levels among different sub-types of axial spondyloarthritis patients and healthy controls	4
Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis	4
RS3PE syndrome: Autoinflammatory features of a rare disorder	4
Clinical efficacy of alternative TNF inhibitor and secukinumab between primary non-responder and secondary non-responder of prior TNF inhibitor in ankylosing spondylitis	4
Differences in knee joint degeneration between primary hip osteoarthritis and hip osteoarthritis secondary to hip developmental dysplasia: A propensity score-based analysis	4
Chest computed tomography findings of adult patients with antimelanoma differentiation-associated protein 5 antibody-positive interstitial lung disease	4
Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren’s syndrome	4
Vitamin D receptor expression in SLE peripheral blood CD4+T cells is associated with disease activity and cell apoptosis	4
Prevalence and risk factors of monoclonal gammopathy in patients with autoimmune inflammatory rheumatic disease: A systematic review and meta-analysis	4
Similar short-term KOOS between open-wedge high tibial osteotomy and total knee arthroplasty in patients over age 60: A propensity score–matched cohort study	4
Global research trends in hyperuricemia: a bibliometric and visualized study	4
Neck pain and related factors in patients with rheumatoid arthritis	4
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry	4
Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography	4
Phenotypic landscape of systemic lupus erythematosus: An analysis of the Kyoto Lupus Cohort	4
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis	4
What is the impact of methotrexate on liver in patients with juvenile idiopathic arthritis? Results of liver SWE performed in a single centre	4
The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey	4
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour	4
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management o	4
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry	4
Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis	4
Evaluation of vitamin D profile in juvenile idiopathic arthritis	4
A retrospective, longitudinal study of rheumatoid arthritis treatment patterns with Janus kinase inhibitors and other disease-modifying antirheumatic drugs in Japan	4
Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy – a study using dual-energy computed tomography	4
Anti-ganglionic nicotinic acetylcholine receptor α3 subunit antibody as a potential biomarker associated with lupus enteritis	4
Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation	4
Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren’s syndrome-related sialadenitis	4
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary	4
Proximal heat stress up-regulates angiopoietin-1 in fingers and reduces the severity of Raynaud’s phenomenon in systemic sclerosis: a single-centre pilot study	4
Clinical features of paediatric immunoglobulin A vasculitis patients with scrotal involvement	4
Central sensitisation in primary Sjögren Syndrome and its effect on sleep quality	4
Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis	4
The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases	4
High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study	4
Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospec	4
Epidemiology and clinical characteristics of systemic sclerosis overlap syndrome (SSc-OS), and the factors significantly associated with SSc-OS in Thai patients with systemic sclerosis	3
Involvement of two or more sets of lacrimal glands and/or major salivary glands is related to greater systemic disease activity due to multi-organ involvement in IgG4-related dacryoadenitis/sialadenit	3
Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4)	3
Clinical features and outcomes of spine surgery in patients with ankylosing spondylitis	3
The development of knee osteoarthritis and serum carotenoid levels among community-dwelling people in Japan	3
COVID-19-associated multisystem inflammatory syndrome in children: Experiences of three centres in Turkey	3
Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and pre-existing diabet	3
Treatment practices and costs among patients with psoriatic arthritis: A Japanese hospital claims database analysis	3
Clinical observations of osteoporosis in Japanese patients with rheumatoid arthritis	3
Safety and tolerability of ultrasound-guided synovial needle biopsy in Japanese arthritis patients	3
Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medi	3
Tacrolimus use and renal function in pregnancy with lupus nephritis: Analysis of post-marketing surveillance data in Japan	3
Management review of scleroderma renal crisis: An update with practical pointers	3
Clinical characteristics of patients with polyarteritis nodosa based on a nationwide database in Japan	3
The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis	3
Real-world safety and effectiveness of canakinumab in patients with tumour necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: Interim results from post-marke	3
Thirteen-year results of cementless total hip arthroplasty with zirconia heads on highly cross-linked polyethylene	3
Relationships between Type 1 interferon signatures and clinical features of the new-onset lupus patients in Japan	3
Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis	3
Use of mycophenolate mofetil for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database	3
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analy	3
The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis	3
Effects of the COVID-19 pandemic on body composition among patients with rheumatoid arthritis	3
The aberrant levels of decorin induce damages of human salivary gland epithelial cells and polarization of macrophages	3
Cardiovascular burden in systemic sclerosis: QRISK3 versus Framingham for risk estimation	3
Fertility preservation in patients receiving gonadotoxic therapies for systemic autoimmune diseases in Japan	3
miRNAs as attractive diagnostic and therapeutic targets for Familial Mediterranean Fever	3
Prevalence of radiographic hip dysplasia in Japanese population-based study	3
High-fat diet-induced obesity accelerates the progression of spontaneous osteoarthritis in senescence-accelerated mouse prone 8	3
Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression	3
Tocilizumab can efficiently prevent bone destruction in patients with recent-onset rheumatoid arthritis	3
Periodontitis severity affects the clinical response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis: A 1-year follow-up study	3
Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease	3
The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: A systematic review and meta-analysis	3
Cluster analysis of paediatric Behçet’s disease: Data from The Pediatric Rheumatology Academy-Research Group	3
Post-marketing surveillance of high-dose methotrexate (>8 mg/week) in Japanese patients with rheumatoid arthritis: A post hoc sub-analysis of patients according to duration of prior methotrexate us	3
Predictive factors for achievement of treatment goals in patients with postmenopausal osteoporosis treated with denosumab	3
Efficacy and safety of abatacept in biologic-naïve patients with active rheumatoid arthritis by background methotrexate dose:post hocanalysis of a randomized, placebo-controlled, phase 4 study	3
Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity	3
High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study	3
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study	3
Impact of social support on severity of depressive symptoms by remission status in patients with rheumatoid arthritis	3
Treatment of systemic JIA: When do we need a biologic? Real world data of a single center	3
Urinary abnormality in mixed connective tissue disease predicts development of other connective tissue diseases and decrease in renal function	3
Evaluation of locomotive syndrome in patients receiving surgical treatment for degenerative musculoskeletal diseases: A multicentre prospective study using the new criteria	3
Risk factors that hinder locomotive syndrome improvement following surgery for musculoskeletal diseases in older patients: A multicentre prospective study	3
Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020	3
Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a singl	3
A multicentre study of clinical features and HLA typing in Japanese patients with ankylosing spondylitis	3
Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity	3
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis	3
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicente	3
C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant gluco	3
Trends in treatment for patients with late-onset rheumatoid arthritis in Japan: Data from the NinJa study	3
Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor	3
Role of rituximab in the treatment of systemic sclerosis: A literature review	3
Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study	3
Use of biologics for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database	3
Expert perspectives on pathological findings in vasculitis	2